Northborne Partners is pleased to announce the release of its 2023 Precision Medical Manufacturing Review and 2024 Outlook. This detailed report provides insight into the following areas of medical contract manufacturing:
Northborne Partners continues to be extremely active in medical device manufacturing and medtech, more broadly. We have compiled our 2024 outlook based on real-time experience representing multiple clients in the space and conversations with leading industry participants and executives.
Please see the following link to download Northborne’s Precision Medical Manufacturing 2023 Review and 2024 Outlook: Medical Manufacturing 2023 Review 2024 Outlook
For a copy of the full report, please contact one of the Northborne medical manufacturing services team members below.
Website includes transactions completed by Northborne professionals at prior firms.